Chemomab Announces Appointment of Mitchell L. Jones, MD, PhD as Vice President of Corporate Development and Strategy

TEL AVIV, Israel, Nov. 30, 2022 -- (Healthcare Sales & Marketing Network) -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB) (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and... Biopharmaceuticals, Personnel Chemomab Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news